PAPER Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ
SEARCH RESULTS
331007 RESULTS
ASCL1
ANTIBODY polyclonal manufacturer Cat# LS-C97682 immunogen = synthetic peptide selected from the C-terminal region of human Mash1 liquid, PBS, azide, protein G purified ASCL1/ASH1/MASH 1 IgG Transcription Factors LifeSpan Biosciences, Inc. Rabbit Human Mouse ASCL1
ASCL1
ANTIBODY polyclonal manufacturer Cat# ab74624 immunogen = synthetic peptide derived from within residues 150 to the C-terminus of human MASH1/Achaete-scute homolog 1, conj. to KLH liquid, PBS, azide, BSA, affinity purified ASCL1/ASH1/MASH 1 expect rat, cow, dog, m
ASCL1
ANTIBODY polyclonal manufacturer Cat# ab71197 immunogen = synthetic peptide corresp. to aa residues surrounding L68 of human Achaete-scute homolog 1 conjugated to KLH liquid, PBS, azide, ammonium sulfate ppt ASCL1/ASH1/MASH 1 IgG Transcription Factors Abcam Rabbit
ASCL1
ANTIBODY monoclonal manufacturer Cat# ab76987 immunogen = recombinant fragment corresp. to aa137-237 of human Achaete-scute homolog 1 (NP_004307) liquid, PBS, no preservative, affinity purified ASCL1/ASH1/MASH 1 expect mouse, rat, chicken, xenopus, zebrafish IgG&l
ASCL1
ANTIBODY polyclonal manufacturer Cat# ab74065 immunogen = synthetic peptide derived from within residues 200 to the C-terminus of human MASH1/Achaete-scute homolog 1, conjugated to KLH liquid, PBS, BSA, azide, affinity purified ASCL1/ASH1/MASH 1 expect chicken, do
ASCL1a
ANTIBODY polyclonal manufacturer Cat# ab82486 immunogen = synthetic peptide: Q C S N K S A S K Q A K R Q R, corresp. to internal sequence aa36-50 of zebrafish ascl1a (NP_571294.1) liquid, TBS, BSA, azide, affinity purified ASCL1/ASH1/MASH 1 IgG Transcription Facto
PAPER Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.
Neurology. 2009 Apr 14;72(15):1296-300. PubMed: 19109537PAPER Rongve A, Brønnick K, Ballard C, Aarsland D
Core and suggestive symptoms of dementia with lewy bodies cluster in persons with mild dementia.
Dement Geriatr Cogn Disord. 2010;29(4):317-24. PubMed: 20389073PAPER Schenck CH, Bundlie SR, Mahowald MW
Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.
Neurology. 1996 Feb;46(2):388-93. PubMed: 8614500PAPER Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, Martinez-Carrasco I, Connolly L, He Z
SOCS3 deletion promotes optic nerve regeneration in vivo.
Neuron. 2009 Dec 10;64(5):617-23. PubMed: 20005819Simone Lista
Miguel de Cervantes European University (UEMC)Valladolid, Spain
TARDPB /TDP-43
ANTIBODY polyclonal manufacturer ab50930 immunogen = region within synthetic peptide: MSEYIRVTED ENDEPIEIPS EDDGTVLLST VTAQFPGACG LRYRNPVSQC, corresponding to N terminal amino acids 1-50 of Human TARDBP liquid, protein-A purified, sucrose, PBS, no preservative 45k
TARDPB /TDP-43
ANTIBODY monoclonal manufacturer ab57105 immunogen = recombinant full length protein, corresponding to amino acids 1-261 of Human TARDBP liquid, protein-G purified, PBS, no preservative 45kDa TARDBP others not tested IgG<sub>1</sub>,κ TAR DNA-binding p
Paralysis Lost: Acting-Out Dreams Precede Parkinson’s Dementia
RESEARCH NEWS 2010-08-06 Research News Paralysis is not always a bad thing—during sleep, it is essential to prevent us from acting out our dreams, for example, by physically tackling the “bear” we’re fighting off. But that paralysis is lost in a condition called rapid eye movemen
Current Filters
No filters selected